Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,763,549
+$3,120,612 QoQ
Shares Held
219,815
+96.0% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#70
of 271 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Derivatives in ARQT

reported options exposure · as of Jun 30, 2026
CallValue
$8,741,748
CallShares
333,400
PutValue
$456,228
PutShares
17,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. ARQT ranks #41 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in ARQT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,763,549 219,815
2026-06-30 $456,228 17,400
2026-06-30 $8,741,748 333,400
2026-03-31 $209,684 8,900
2026-03-31 $2,642,937 112,179
2026-03-31 $3,409,132 144,700
2025-12-31 $7,910,496 272,400
2025-12-31 $257,497 8,867
2025-12-31 $868,296 29,900
2025-09-30 $1,236,484 65,596
2025-09-30 $2,510,820 133,200
2025-09-30 $1,568,320 83,200
2025-06-30 $1,329,096 94,800
2025-06-30 $1,988,036 141,800
2025-06-30 $3,659,037 260,987
2025-03-31 $2,637,279 168,624
2025-03-31 $1,651,584 105,600
2025-03-31 $4,568,444 292,100
2024-12-31 $3,364,095 241,500
2024-12-31 $1,586,627 113,900
2024-12-31 $892,926 64,101
2024-09-30 $467,669 50,287
2024-09-30 $457,560 49,200
2024-09-30 $1,674,000 180,000
2024-06-30 $1,509,390 162,300
2024-06-30 $797,010 85,700
2024-06-30 $508,551 54,683
2024-03-31 $2,986,874 301,400
2024-03-31 $4,089,857 412,700
2024-03-31 $993,189 100,221
2023-12-31 $1,062,272 328,877
2023-12-31 $46,189 14,300
2023-12-31 $114,988 35,600
2023-09-30 $197,532 37,200
2023-09-30 $203,335 38,293
2023-06-30 $342,127 35,900
2023-06-30 $141,815 14,881
2023-06-30 $1,098,809 115,300
2023-03-31 $1,169,894 106,354
2023-03-31 $301,400 27,400
2022-12-31 $330,069 22,302
2022-12-31 $2,560,400 173,000
2022-09-30 $1,156,059 60,495
2022-09-30 $338,247 17,700
2022-09-30 $806,442 42,200
2022-06-30 $575,370 27,000
2022-06-30 $739,052 34,681
2022-03-31 $365,940 19,000
2022-03-31 $374,260 19,432
2021-12-31 $597,312 28,800